APD334-003

APD334-003 · Arena Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for APD334-003, covering 2021-11-26 to 2021-11-26. Get the full timeline:

Most recent: Clinical Trial Update: Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis [Phase 2]